Authors:
Bargoni, A
Cavalli, R
Zara, GP
Fundaro, A
Caputo, O
Gasco, MR
Citation: A. Bargoni et al., Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II - Tissue distribution, PHARMAC RES, 43(5), 2001, pp. 497-502
Authors:
Cavalli, R
Zara, GP
Caputo, O
Bargoni, A
Fundaro, A
Gasco, MR
Citation: R. Cavalli et al., Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I - A pharmacokinetic study, PHARMAC RES, 42(6), 2000, pp. 541-545
Authors:
Fundaro, A
Cavalli, R
Bargoni, A
Vighetto, D
Zara, GP
Gasco, MR
Citation: A. Fundaro et al., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats, PHARMAC RES, 42(4), 2000, pp. 337-343
Authors:
Miglietta, A
Cavalli, R
Bocca, C
Gabriel, L
Gasco, MR
Citation: A. Miglietta et al., Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel, INT J PHARM, 210(1-2), 2000, pp. 61-67
Authors:
Podio, V
Zara, GP
Carazzone, M
Cavalli, R
Gasco, MR
Citation: V. Podio et al., Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats, J PHARM PHA, 52(9), 2000, pp. 1057-1063
Citation: R. Cavalli et al., Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins, INT J PHARM, 182(1), 1999, pp. 59-69